Find the investors funding DeepTech rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
Vilnius-based Biomatter raises €16.2 million to make AI-designed custom enzymes not found in nature - EU-Startups
Biomatter is a startup focused on creating AI-designed custom enzymes that are not found in nature. Their innovative approach leverages artificial intelligence to design enzymes for various applications, potentially transforming industries that rely on biocatalysis. The recent funding will help them advance their technology and expand their market reach.
Vilnius-based Biomatter raises €16.2 million to make AI-designed custom enzymes not found in nature EU-Startups
| Oct 18, 2026 | EnforceShield | $2.0M | Seed | Lithuania |
| Sep 15, 2026 | EnforceShield | $1.8M | Seed | Lithuania |
| Aug 24, 2026 | Guideless | $1.1M | Pre-seed | Lithuania |
| Jul 29, 2026 | Sigvi | $1.3M | — | Lithuania |
You just read who funded Biomatter. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.